Anticancer agent 231
Product Specifications
CAS Number
128519-30-2
Target
ERK
Related Pathways
MAPK
Bioactivity
Anticanceragent 231 (compound P5) is a tyrosine kinase inhibitor with an IC50 value of 3.95 μM. It targets the EGFR-ERK1/2 signaling pathway, reducing cell viability, proliferation, migration, and cancer stemness in triple-negative breast cancer (TNBC) cells, potentially playing a significant role in the treatment of TNBC.
Smiles
ClC=1C=CC(=CC1)C2=NN(C=3C=CC=CC3)C(C4=CC=C(C=C4)N(C)C)C2
Molecular Formula
C23H22ClN3
Molecular Weight
375.89
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
